DLBCL GERMINAL CENTER B-CELL TYPE
Clinical trials for DLBCL GERMINAL CENTER B-CELL TYPE explained in plain language.
Never miss a new study
Get alerted when new DLBCL GERMINAL CENTER B-CELL TYPE trials appear
Sign up with your email to follow new studies for DLBCL GERMINAL CENTER B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost CAR t-cell success in hard-to-treat blood cancers
Disease control Recruiting nowThis early-phase study tests a radioactive drug (131-I apamistamab) given before CAR T-cell therapy for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. The goal is to find a safe dose and see if the combination is tolera…
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New drug SGR-1505 enters early human testing for B-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called SGR-1505 in about 98 adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to find the safest dose and understand side effects. Participants must have measurable disease and be well enough for dail…
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC